Lineage Cell Therapeutics, Inc. logo

Lineage Cell Therapeutics, Inc.

AMEX:LCTX

Overview | Financials
Company Name Lineage Cell Therapeutics, Inc.
Symbol LCTX
Currency USD
Price 0.95
Market Cap 166,237,658
Dividend Yield 0%
52-week-range 0.93 - 1.58
Industry Biotechnology
Sector Healthcare
CEO Mr. Brian M. Culley M.A., M.B.A.
Website https://www.lineagecell.com

An error occurred while fetching data.

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular

Related Stocks

Zomedica Corp. logo

Zomedica Corp.

ZOM

0.167 USD

InfuSystem Holdings, Inc. logo

InfuSystem Holdings, Inc.

INFU

9.29 USD

Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc.

ARMP

2.22 USD

Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc.

MTNB

0.235 USD

VolitionRx Limited logo

VolitionRx Limited

VNRX

0.748 USD

Stereotaxis, Inc. logo

Stereotaxis, Inc.

STXS

1.56 USD

CEL-SCI Corporation logo

CEL-SCI Corporation

CVM

2.18 USD

Retractable Technologies, Inc. logo

Retractable Technologies, Inc.

RVP

1.08 USD

Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc.

ATNM

4.49 USD

Cybin Inc. logo

Cybin Inc.

CYBN

0.45 USD

Financials

Numbers are in millions USD

Numbers are in millions USD